Literature DB >> 17687574

The potential application of gene therapy in the treatment of traumatic brain injury.

Fang Shen1, Liang Wen, Xiaofeng Yang, Weiguo Liu.   

Abstract

Advances in molecular biology have allowed the possibility of using gene therapy in the treatment of traumatic brain injury. The major tactics involve picking out the appropriate gene target and, by controlling its specific regional expression, inhibiting neuronal cell deaths and/or promoting neuronal regeneration. This review addresses the preliminary usage of gene therapy in in vitro experiments and in animal models to treat traumatic brain injury. The gene targets with therapeutic potentials, the vectors that can be employed to deliver the candidate genes, as well as different approaches for gene therapy are discussed in detail in this review. Despite the existence of several major obstacles to making it practical and effective, gene therapy could provide a new strategy for treatment of the traumatically injured brain.

Entities:  

Mesh:

Year:  2007        PMID: 17687574     DOI: 10.1007/s10143-007-0094-4

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  56 in total

1.  Inflammatory responses and their impact on beta-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus.

Authors:  M S Lawrence; H G Foellmer; J D Elsworth; J H Kim; C Leranth; D A Kozlowski; A L Bothwell; B L Davidson; M C Bohn; D E Redmond
Journal:  Gene Ther       Date:  1999-08       Impact factor: 5.250

2.  Neuroprotective and behavioral efficacy of nerve growth factor-transfected hippocampal progenitor cell transplants after experimental traumatic brain injury.

Authors:  M F Philips; G Mattiasson; T Wieloch; A Björklund; B B Johansson; G Tomasevic; A Martínez-Serrano; P M Lenzlinger; G Sinson; M S Grady; T K McIntosh
Journal:  J Neurosurg       Date:  2001-05       Impact factor: 5.115

Review 3.  Towards multifunctional synthetic vectors.

Authors:  Barbara Demeneix; Zahra Hassani; Jean-Paul Behr
Journal:  Curr Gene Ther       Date:  2004-12       Impact factor: 4.391

Review 4.  Harnessing HIV for therapy, basic research and biotechnology.

Authors:  Maciej Wiznerowicz; Didier Trono
Journal:  Trends Biotechnol       Date:  2005-01       Impact factor: 19.536

5.  Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins.

Authors:  Hrvoje Miletic; Yvonne Heidemarie Fischer; Harald Neumann; Volkmar Hans; Werner Stenzel; Tsanan Giroglou; Manuel Hermann; Martina Deckert; Dorothee Von Laer
Journal:  Hum Gene Ther       Date:  2004-11       Impact factor: 5.695

6.  Tf-lipoplex-mediated NGF gene transfer to the CNS: neuronal protection and recovery in an excitotoxic model of brain injury.

Authors:  M Teresa Girão da Cruz; A L C Cardoso; L P de Almeida; S Simões; M C Pedroso de Lima
Journal:  Gene Ther       Date:  2005-08       Impact factor: 5.250

Review 7.  Maintaining the neuronal phenotype after injury in the adult CNS. Neurotrophic factors, axonal growth substrates, and gene therapy.

Authors:  M H Tuszynski; F H Gage
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

8.  Cerebral metabolism following neonatal or adult hemineodecortication in cats: I. Effects on glucose metabolism using [14C]2-deoxy-D-glucose autoradiography.

Authors:  D A Hovda; J R Villablanca; H T Chugani; M E Phelps
Journal:  J Cereb Blood Flow Metab       Date:  1996-01       Impact factor: 6.200

9.  Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.

Authors:  Cédric Raoul; Toufik Abbas-Terki; Jean-Charles Bensadoun; Sandrine Guillot; Georg Haase; Jolanta Szulc; Christopher E Henderson; Patrick Aebischer
Journal:  Nat Med       Date:  2005-03-13       Impact factor: 53.440

10.  Posttraumatic cerebral ischemia after fluid percussion brain injury: an autoradiographic and histopathological study in rats.

Authors:  W D Dietrich; O Alonso; R Busto; R Prado; W Zhao; M K Dewanjee; M D Ginsberg
Journal:  Neurosurgery       Date:  1998-09       Impact factor: 4.654

View more
  4 in total

1.  Localized cell and drug delivery for auditory prostheses.

Authors:  Jeffrey L Hendricks; Jennifer A Chikar; Mark A Crumling; Yehoash Raphael; David C Martin
Journal:  Hear Res       Date:  2008-06-07       Impact factor: 3.208

Review 2.  Cell therapy for CNS trauma.

Authors:  K K Jain
Journal:  Mol Biotechnol       Date:  2009-03-28       Impact factor: 2.695

Review 3.  Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases.

Authors:  Della Grace Thomas Parambi; Khalid Saad Alharbi; Rajesh Kumar; Seetha Harilal; Gaber El-Saber Batiha; Natália Cruz-Martins; Omnia Magdy; Arafa Musa; Dibya Sundar Panda; Bijo Mathew
Journal:  Mol Neurobiol       Date:  2021-10-15       Impact factor: 5.682

4.  Effects of lyoprotectants on long-term stability and transfection efficacy of lyophilized poly(lactide-co-glycolide)-graft-polyethylenimine/plasmid DNA polyplexes.

Authors:  Joshua Woo; Jeoung Soo Lee
Journal:  Nanomedicine (Lond)       Date:  2021-05-28       Impact factor: 5.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.